Geneseeq Receives NMPA Approval for PanTRKare™ - China's First NGS-Based Pan-Solid Tumor ...

Geneseeq Technology Inc., a global precision oncology company, today announced its PanTRKare™NTRK1/NTRK2/NTRK3 Gene Fusion ...